HDAC9 and Miyoshi myopathy: Because panobinostat increased IFN-γR1 expression in MM cells at mRNA as well as protein levels, panobinostat is suggested to at least in part enhance transcription of IFN-γR1 gene through its HDAC inhibitory activity.